The standard procedure for the detection of NB MYCN amplification is tumour biopsies from the primary site of presentation or metastatic sites, including the bone marrow and subsequent fluorescence in situ hybridisation (FISH) [18]. This evidence concerns the gene MYCN and neoplasm.